GLP‑1 Diet Effect
- An app-based analysis found GLP-1 users consumed fewer total calories but did not change macronutrient ratios. - Users ate less overall without shifting protein, fat, and carbs proportions versus nonusers. - That pattern suggests appetite suppression reduces intake but may not automatically protect muscle without intentional protein-focused planning (healio.com).
Glucagon-like peptide 1 drugs work in part by blunting appetite, and a new app-based analysis found users mostly ate less of everything, not a different mix of foods. (healio.com) Researchers analyzed 5,741 days of food logs from 332 adults with overweight or obesity who used the Robin Health app between July 2025 and February 2026. Of them, 116 reported using a glucagon-like peptide 1 medicine and 216 did not. (imt.ie) The study is scheduled for presentation at the 33rd European Congress on Obesity in Istanbul, Türkiye, on May 12-15, 2026, and was led by Valentina Vinelli of IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University in Milan with the Robin Health team. (eco2026.org) (medicalxpress.com) People using a glucagon-like peptide 1 drug reported eating 1,102 calories a day on average, versus 1,281 calories for nonusers. They also logged less protein, 53.8 grams versus 62 grams, fewer carbohydrates, 128 grams versus 143 grams, and less fat, 39.7 grams versus 45.7 grams. (healio.com) But the share of calories from each macronutrient barely moved: protein was 19.9% of intake in users versus 18.9% in nonusers, carbohydrates were 46.7% versus 46.2%, and fat was 32.7% versus 33.5%. The pattern points to appetite suppression that shrinks the whole plate rather than steering people toward a higher-protein diet. (healio.com) Protein is the nutrient the body uses to maintain muscle, and the study found 87.9% of users did not meet protein targets from the Italian Society of Human Nutrition. Users also skipped breakfast on 31.3% of logged days, lunch on 30.5%, and dinner on 40.4%, all higher than the rates in nonusers. (healio.com) That concern lines up with a separate 2026 preliminary study of 387 adults taking glucagon-like peptide 1 or dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 drugs. In that group, average intake was 753 calories and 33.4 grams of protein a day, and fewer than 10% met recommended protein intake. (pmc.ncbi.nlm.nih.gov) A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society said nutrition and resistance exercise should accompany these medicines. The advisory said lower food intake can make protein, fiber, fluid, and micronutrient planning more important during treatment. (ajcn.nutrition.org) The new data do not show that the drugs themselves cause poor diet quality, because the analysis relied on self-reported app logs and compared users with nonusers at one point in time rather than following the same people before and after treatment. The result is narrower: many users appear to eat less overall without automatically changing what proportion of their diet comes from protein, fat, or carbohydrates. (healio.com) (pmc.ncbi.nlm.nih.gov)
